-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Esperion Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q2 2024.
- Esperion Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was 1.78 %.
- Esperion Therapeutics, Inc. annual Operating Margin for 2023 was -134 %, a 43.8% increase from 2022.
- Esperion Therapeutics, Inc. annual Operating Margin for 2022 was -238 %, a 17.7% increase from 2021.
- Esperion Therapeutics, Inc. annual Operating Margin for 2021 was -289 %, a 442% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)